title: MC1R and PTCH gene polymorphism in French patients with basal cell carcinomas.
abstract: In this study, we assessed the role of melanocortin 1 receptor (MC1R) variants and of two patched (PTCH) polymorphisms (c.3944C>T (P1315L), insertion 18 bp IVS1-83) as risk factors for basal cell carcinoma (BCC) in the French population. The population investigated comprised 126 BCC patients who were enrolled on the basis of specific criteria (multiple and/or familial BCC and/or onset before the age of 40 years and/or association with another tumor)--and 151 controls matched for ethnicity, age, and sex. MC1R variants appeared as a moderate risk factor for BCC (odds ratio (OR) for one and two variants, 2.17 [1.28-3.68] and 7.72 [3.42-17.38], respectively), independently of pigmentation characteristics (OR = 2.53 [1.34-4.8]). Interestingly, in addition to the predictable red hair color (RHC) alleles, two non-RHC alleles (V60L and V92M) were also closely associated with BCC risk (OR 3.21 [1.91-5.38] and 2.87 [1.5-5.48], respectively), which differs from the situation in the Celtic population. In addition, the PTCH c.3944C/C genotype was also associated with BCC risk (OR 1.94 [1.2-3.1]), especially in the subgroup of patients with multiple tumors (OR 2.16 [1.3-3.6]). Thus, our data show that MC1R and PTCH variants are associated with BCC risk in the French population. We further suggest that assessing MC1R and PTCH status could be useful, combined with the assessment of clinical risk factors, in identifying high-risk patients to be targeted for prevention or more rigorous surveillance.
authors.affiliation: INSERM U716, Paris, France.
authors.forename: Muriel
authors.initials: M
authors.lastname: Liboutet
authors.forename: Marc
authors.initials: M
authors.lastname: Portela
authors.forename: Gisèle
authors.initials: G
authors.lastname: Delestaing
authors.forename: Catherine
authors.initials: C
authors.lastname: Vilmer
authors.forename: Nicolas
authors.initials: N
authors.lastname: Dupin
authors.forename: Isabelle
authors.initials: I
authors.lastname: Gorin
authors.forename: Philippe
authors.initials: P
authors.lastname: Saiag
authors.forename: Céleste
authors.initials: C
authors.lastname: Lebbé
authors.forename: Delphine
authors.initials: D
authors.lastname: Kerob
authors.forename: Louis
authors.initials: L
authors.lastname: Dubertret
authors.forename: Bernard
authors.initials: B
authors.lastname: Grandchamp
authors.forename: Nicole
authors.initials: N
authors.lastname: Basset-Seguin
authors.forename: Nadem
authors.initials: N
authors.lastname: Soufir
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002280:Basal Cell Carcinoma / Q000208:ethnology / Q000235:genetics*; D016022:Case-Control Studies; D005260:Female; D005602:France / Q000208:ethnology; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D006200:Hair Color; D006801:Humans; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D000072079:Patched Receptors; D000072081:Patched-1 Receptor; D011110:Polymorphism, Genetic; D011446:Prospective Studies; D044102:Receptor, Melanocortin, Type 1 / Q000235:genetics* / Q000502:physiology; D011956:Receptors, Cell Surface / Q000235:genetics* / Q000502:physiology; D012044:Regression Analysis; D012307:Risk Factors; D012878:Skin Neoplasms / Q000208:ethnology / Q000235:genetics*; D044465:White People / Q000235:genetics
chemical_list: C000606236:PTCH1 protein, human; D000072079:Patched Receptors; D000072081:Patched-1 Receptor; D044102:Receptor, Melanocortin, Type 1; D011956:Receptors, Cell Surface